Clinical Certificate

Anxiety Disorders

Date: Thursday 24th January 2019 – Friday 25th January 2019
Venue: The Bristol Hotel, Prince Street, Bristol, BS1 4QF
Accommodation: The Bristol Hotel, Prince Street, Bristol , BS1 4QF
(accommodation is chargeable separately when you complete the online booking form)
Organised by: David Nutt and John Potokar

Book online Pay By Invoice

Programme

Thursday 24 January
13:00–13:30 Arrival, registration and light lunch
13:30–13:35 Introduction
Dr John Potokar (Bristol)
13:35–15:00 Evidence-based pharmacological treatment of anxiety disorders
Professor David Baldwin (Southampton)
15:00–15:15 Refreshments
15:15–16:30 Two Groups
Group A: Anxiety in the Medical Setting
Dr John Potokar (Bristol) and Dr Nicola Taylor (Bristol)
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law (Bristol) and Dr Jan Melichar (Bristol)
16:30–16:45 Refreshments and presenters swap rooms
16:45–18:00 Two Groups (repeated)
Group A: Anxiety in the Medical Setting
Dr John Potokar (Bristol) and Dr Nicola Taylor (Bristol)
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law (Bristol) and Dr Jan Melichar (Bristol)
18:00 End of Thursday Sessions
Friday 25 January
08:45–09:15 Arrival and Coffee
09:15–10:45 The fast and the slow: exploring the duality of anxiolytic action
Professor David Nutt (London)
10:45–11:00 Refreshments
11:00–12:30 Practical therapy of anxiety: case studies
Professor David Nutt (London) and Dr David Christmas (Cambridge)
12:30–13:15 Lunch
13:15–14:30 Two Groups
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt (London) and Dr David Christmas (Cambridge)
Group B: Insomnia and other Sleep Disturbances
Dr Hugh Selsick (London) and Dr David O'Regan (London)
14:30–14:45 Refreshments and presenters swap rooms
14:45–16:00 Two Groups (repeated)
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt (London) and Dr David Christmas (Cambridge)
Group B: Insomnia and other Sleep Disturbances
Dr Hugh Selsick (London) and Dr David O'Regan (London)
16:00 End of meeting, return of feedback forms

Last edited 10th April 2018

Learning Objectives

At the end of one and a half day course, delegates will:

  • Be aware of current theories and the causes and neurochemistry of anxiety.
  • Know the pharmacology of both GABA and 5-HT acting anxiolytic drugs.
  • Have an understanding of the current clinical assessment of the various anxiety disorders.
  • Be aware of the merits and demerits of the various different classes of anxiolytic agents.
  • Understand the ongoing methodologies for investigating brain mechanisms of anxiety.
  • Know the clinical and pharmacology background of underpinning rational use of hypnotics.
  • Have an insight into the way alcohol acts on the brain and how these effects can be minimised.

This module is eligble for 10 CPD hours which are subject to peer group review.

Feedback from 2018 Module

"Excellent course, many thanks"

"Exceptional conference – it will definitely impact on my clinical practice. I will highly recommend to my colleagues!"

"I have now finished my Part 1 BAP Certificate and can say that overall BAP courses are the best in the country and I recommend them to all junior colleagues. We are always looked after well and everything is well-organised"

Print DOIs